News Detail
United Kingdom, 3 Feb 2025: The medical device industry is facing increasing regulatory scrutiny regarding the use of PVC materials containing Di(2-ethylhexyl) Phthalate (DEHP), a known endocrine disruptor. Both the FDA&rs......
View Details
Source : Henkel Ltd
PVC materials
Di(2-ethylhexyl) Phthalate (DEHP)
endocrine disruptor
thermoplastic elastomers (TPEs)
Loctite AA 3952
Loctite SI 5057
Related News
- Alkem launches Kojiglo serum to manage facial hyperpigmentation (05-02-2025)
- NPPP 2012 lays down the regulatory framework for pricing of drugs (05-02-2025)
- Government Tightens Drug Quality Regulations (05-02-2025)
- UCPMP 2024 to prevent unethical marketing (05-02-2025)
- Addressing the Issue of Blood Black Marketing: The Need for Regulatory Measures (05-02-2025)
- Pharmacist arrested for deceiving female officers by impersonating an IAS officer (05-02-2025)
- Assam Rifles seized 6,900 Eskuf Cough Syrup Bottles worth Rs. 40 lakh from Nagicherra (04-02-2025)
- Illegal Call Center Busted in Sakinaka: 6 Arrested, Electronic Devices Seized (04-02-2025)
- IIT Guwahati researchers develop new trial method for personalised care (04-02-2025)
- Team will go to the companies making heavy doses of narcotic drugs, after checking the records, will ban them from supplying them (04-02-2025)